Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Ekso Bionics Holdings Inc (EKSO) USD0.001

Sell:$0.60 Buy:$0.60 Change: $0.0115 (1.89%)
NASDAQ:0.13%
Market closed |  Prices as at close on 11 November 2019 | Switch to live prices |
Sell:$0.60
Buy:$0.60
Change: $0.0115 (1.89%)
Market closed |  Prices as at close on 11 November 2019 | Switch to live prices |
Sell:$0.60
Buy:$0.60
Change: $0.0115 (1.89%)
Market closed |  Prices as at close on 11 November 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ekso Bionics Holdings, Inc., formerly PN Med Group, Inc., designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military and consumer markets. The Company operates through two segments: Engineering Services and Medical. The Engineering Services segment is engaged in collaborative research and development service arrangements, technology license agreements and government grants where it uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities, such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical segment designs, engineers and manufactures exoskeletons for applications in the medical and military markets. The Company's exoskeleton systems are worn over the user's clothing. The exoskeleton systems serve various markets, which can be used both by able-bodied users, as well as by persons with physical disabilities.

Contact details

Address:
1414 Harbour Way S Ste 1201
RICHMOND
94804-3628
United States
Telephone:
+1 (510) 9841761
Website:
https://ir.eksobionics.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EKSO
ISIN:
US2826442020
Market cap:
$45.72 million
Shares in issue:
74.95 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Steven Sherman
    Executive Chairman of the Board
  • Jack Peurach
    President, Chief Executive Officer, Director
  • John Glenn
    Chief Financial Officer, Secretary
  • Matthias Stief
    Managing Director
  • Bill Shaw
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.